A large investment of at least US$3.9 billion needed to meet the World Health Organization’s (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health. Pakistan has one…
Category: News
News: International liver associations call for simplified & more accessible hepatitis C care
In November, representatives from international liver associations called for hepatitis C testing and treatment to be simplified globally. Spearheaded by the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), the Latin American Association for the Study of the Liver (ALEH) and the Asian Pacific…
News: Class-action lawsuit filed in Nevada alleging hepatitis C care inaccessible to people in prison
In the United States, a federal class-action lawsuit was filed last month alleging that people incarcerated in Department of Corrections facilities in the state of Nevada do not have adequate access to direct-acting antivirals (DAAs), the standard of care for the treatment and cure of chronic hepatitis C. According to an article in the Las…
News: Four countries agree to lead the way on an intersectoral approach to HIV, TB & viral hepatitis
Belarus, Georgia, Portugal and Tajikistan have agreed to lead the way in adopting approaches to HIV, tuberculosis (TB) and viral hepatitis that include cooperation with sectors outside of health care. This pilot initiative follows the 2018 launch of the United Nations common position on ending HIV, TB and viral hepatitis through intersectoral collaboration. Signed by 14 United…
News: Europe’s hepatitis challenge
An article published in the Bulletin of the World Health Organization (WHO) this month looks at the factors slowing progress in preventing and treating hepatitis B and C infections in Europe. Experts consulted highlight vaccination, voluntary testing, policy development, a focus on high-risk groups like intravenous drug users, standardized data collection, and service integration as…
News: AbbVie and MPP complete licensing agreement to ensure access to G/P in 99 low and middle-income countries
AbbVie and MPP complete a new licensing agreement to ensure access to G/P in 99 low- and middle-income (LMIC) countries and territories
News: Millions flock to free tests as Egypt seeks to eradicate hepatitis C
Reuters published a story this week on a massive campaign to identify and treat patients suffering from hepatitis C infection in Egypt. The aim of the campaign is to screen the entire adult population — or 50 million people — in an attempt to eliminate the disease from the country by 2022. The campaign, Reuters…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 